215 related articles for article (PubMed ID: 18502571)
1. Prodrug cancer gene therapy.
Altaner C
Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
[TBL] [Abstract][Full Text] [Related]
2. Novel gene-directed enzyme prodrug therapies against prostate cancer.
Russell PJ; Khatri A
Expert Opin Investig Drugs; 2006 Aug; 15(8):947-61. PubMed ID: 16859396
[TBL] [Abstract][Full Text] [Related]
3. Bystander or no bystander for gene directed enzyme prodrug therapy.
Dachs GU; Hunt MA; Syddall S; Singleton DC; Patterson AV
Molecules; 2009 Nov; 14(11):4517-45. PubMed ID: 19924084
[TBL] [Abstract][Full Text] [Related]
4. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
5. Stem cell based cancer gene therapy.
Cihova M; Altanerova V; Altaner C
Mol Pharm; 2011 Oct; 8(5):1480-7. PubMed ID: 21755953
[TBL] [Abstract][Full Text] [Related]
6. Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer.
Khatri A; Russell PJ
Discov Med; 2007 Feb; 7(37):39-45. PubMed ID: 17343804
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
Nouri FS; Wang X; Hatefi A
J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
[TBL] [Abstract][Full Text] [Related]
8. Viral vectors for gene-directed enzyme prodrug therapy.
Schepelmann S; Springer CJ
Curr Gene Ther; 2006 Dec; 6(6):647-70. PubMed ID: 17168697
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Chen L; Waxman DJ
Curr Pharm Des; 2002; 8(15):1405-16. PubMed ID: 12052216
[TBL] [Abstract][Full Text] [Related]
10. Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
Nawa A; Tanino T; Luo C; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Nishiyama Y; Kikkawa F
Anticancer Agents Med Chem; 2008 Feb; 8(2):232-9. PubMed ID: 18288924
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
12. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
[TBL] [Abstract][Full Text] [Related]
13. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
14. Prodrugs in genetic chemoradiotherapy.
Patterson AV; Saunders MP; Greco O
Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
[TBL] [Abstract][Full Text] [Related]
15. From bench to bedside for gene-directed enzyme prodrug therapy of cancer.
Dachs GU; Tupper J; Tozer GM
Anticancer Drugs; 2005 Apr; 16(4):349-59. PubMed ID: 15746571
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors.
Lu YC; Luo YP; Wang YW; Tai CK
Int J Mol Med; 2010 May; 25(5):769-75. PubMed ID: 20372821
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.
Amara I; Touati W; Beaune P; de Waziers I
Biochimie; 2014 Oct; 105():4-11. PubMed ID: 24977933
[TBL] [Abstract][Full Text] [Related]
18. Origins of Suicide Gene Therapy.
Düzgüneş N
Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
[TBL] [Abstract][Full Text] [Related]
19. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
[TBL] [Abstract][Full Text] [Related]
20. Gene-directed enzyme prodrug therapy.
Zhang J; Kale V; Chen M
AAPS J; 2015 Jan; 17(1):102-10. PubMed ID: 25338741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
